본문 바로가기
KERD
논문KCI 등재

Double blind randomized control trial to evaluate the efficacy of ketoprofen patch to attenuate pain during venous cannulation

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Background: Venipuncture pain is an uncomfortable suffering to the patient. It creates anxiety, fear and dissatisfaction. The ketoprofen transdermal patch is a proven treatment for musculoskeletal and arthritic pain. We planned this study to evaluate the efficacy of the ketoprofen patch to reduce venipuncture pain.Methods: Two hundred adult patients, aged 18–60 years, of either sex, ASA grade I or II, were enrolled. Presuming that therapy would decrease venipuncture pain by 30%, a power calculation with  = 0.05 and  = 0.80 required enrollment of at least 24 patients into each group. However, 100 patients in each group were recruited. Group I (Control) received a placebo patch; Group II (Ketoprofen) received a 20 mg ketoprofen patch. A selected vein on the dorsum of the patient’s non-dominant hand was cannulated with 18 g intravenous cannula 1 h after the application of the respective patch. Assessment of pain was done by a 10 cm visual analogue scale (VAS) of 0–10, where 0 depicts “no pain” and 10 is “the worst imaginable pain”. The venipuncture site was assessed for the presence of skin erythema, swelling and rashes at 12 h, 24 h and at the time of decannulation. Results: Incidence of pain was 100% (94/94) in the control group as compared to 93% (85/91) in the ketoprofen group. The severity of the venipuncture pain was 6 (2) and 2 (2) for control and ketoprofen groups respectively (P < 0.05). Conclusions: Application of a ketoprofen patch at the proposed site of venipuncture one hour before the attempt is effective and safe for attenuating venipuncture pain. (Korean J Pain 2018; 31: 39-42)

Abstract

Background: Venipuncture pain is an uncomfortable suffering to the patient. It creates anxiety, fear and dissatisfaction. The ketoprofen transdermal patch is a proven treatment for musculoskeletal and arthritic pain. We planned this study to evaluate the efficacy of the ketoprofen patch to reduce venipuncture pain.Methods: Two hundred adult patients, aged 18–60 years, of either sex, ASA grade I or II, were enrolled. Presuming that therapy would decrease venipuncture pain by 30%, a power calculation with  = 0.05 and  = 0.80 required enrollment of at least 24 patients into each group. However, 100 patients in each group were recruited. Group I (Control) received a placebo patch; Group II (Ketoprofen) received a 20 mg ketoprofen patch. A selected vein on the dorsum of the patient’s non-dominant hand was cannulated with 18 g intravenous cannula 1 h after the application of the respective patch. Assessment of pain was done by a 10 cm visual analogue scale (VAS) of 0–10, where 0 depicts “no pain” and 10 is “the worst imaginable pain”. The venipuncture site was assessed for the presence of skin erythema, swelling and rashes at 12 h, 24 h and at the time of decannulation. Results: Incidence of pain was 100% (94/94) in the control group as compared to 93% (85/91) in the ketoprofen group. The severity of the venipuncture pain was 6 (2) and 2 (2) for control and ketoprofen groups respectively (P < 0.05). Conclusions: Application of a ketoprofen patch at the proposed site of venipuncture one hour before the attempt is effective and safe for attenuating venipuncture pain. (Korean J Pain 2018; 31: 39-42)

참고문헌 (13)

  1. Keane TK, "Non-drug related asystole associated with anaesthetic induction", Anaesthesia, 46, pp.38~39 (1991)[DOI]
  2. Hart PS, "Needle phobia and malignant vasovagal syndrome", Anaesthesia, 53, pp.1002~1004 (1998)[DOI]
  3. Lal MK, "Comparison of EMLA cream versus placebo in children receiving distraction therapy for venepuncture", Acta Paediatr, 90, pp.154~159 (2001)[DOI]
  4. Agarwal A, "Transdermal diclofenac patch vs eutectic mixture of local anesthetics for venous cannulation pain", Can J Anaesth, 54, pp.196~200 (2007)[DOI]
  5. Smith AJ, "Topical ibuprofen for skin analgesia prior to venepuncture", Anaesthesia, 51, pp.495~497 (1996)[DOI]
  6. Agarwal A, "Comparative evaluation of myolaxin and EMLA cream for attenuation of venous cannulation pain: a prospective, randomised, double blind study", Anaesth Intensive Care, 35, pp.726~729 (2007)
  7. Usichenko TI, "Reducing venipuncture pain by a cough trick: a randomized crossover volunteer study", Anesth Analg, 98, pp.343~345 (2004)
  8. Agarwal A, "Evaluating the efficacy of the valsalva maneuver on venous cannulation pain: a prospective, randomized study", Anesth Analg, 101, pp.1230~1232 (2005)[DOI]
  9. 박휴정, "Pharmacologic Management of Chronic Pain", The Korean Journal of Pain, 23(2), pp.99~108 (2010), 대한통증학회
  10. Tripathi KD, "Essentials of medical pharmacology", pp.192~193 (2008), Jaypee Brothers
  11. Massey T, "Topical NSAIDs for acute pain in adults", Cochrane Database Syst Rev (2010)
  12. Komatsu T, "Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe", Eur J Pharm Sci, 47, pp.890~895 (2012)[DOI]
  13. Adachi H, "Physical characteristics, pharmacological properties and clinical efficacy of the ketoprofen patch: a new patch formulation", Eur Rev Med Pharmacol Sci, 15, pp.823~830 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (9건)